HOLLY WILLIS: Open Payments
NPI 1275989345 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 45 payments from 24 companies in 2025. Trend: 2023 $545 · 2024 $929 · 2025 $1,173
Food & beverage: $1,074Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $200 |
| Gilead Sciences, Inc. | 2 | $116 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Cumberland Pharmaceuticals, Inc. | 2 | $69 |
| Astellas Pharma US Inc | 3 | $67 |
| Eisai Inc. | 3 | $53 |
| Genmab U.S., Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: Trodelvy, RYBREVANT, KEYTRUDA, Venclexta, SANCUSO, PLUVICTO, Lenvima, Xtandi.
Industry payments across KY — which companies pay providers there.
